Showing results (1-10 of 380) with videos related to
Sort By:
Pageof 38
Journal of Hematotherapy|June 1, 1999
Peripheral blood stem cell mobilization for high-dose chemotherapyT Demirer, W I Bensinger, C D BucknerStem Cells (Dayton, Ohio)|January 1, 1996
Optimization of peripheral blood stem cell mobilizationT Demirer, C D Buckner, W I BensingerJournal of Clinical Apheresis|May 20, 1998
Tempo of hematologic recovery correlates with peripheral blood CD34+ cell level in patients undergoing stem cell mobilizationO Williams, T Demirer, K Lilleby, et al.Current Opinion in Hematology|May 1, 1995
Optimization of peripheral blood stem cell collectionT Demirer, W I BensingerStem Cells (Dayton, Ohio)|December 1, 1995
Transplantation of allogeneic peripheral blood stem cellsW I Bensinger, F A Appelbaum, T Demirer, et al.Cancer|July 15, 1994
Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed diseaseT Demirer, C D Buckner, K Lilleby, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancerT Demirer, S Rowley, C D Buckner, et al.Blood|March 15, 1995
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factorW I Bensinger, C H Weaver, F R Appelbaum, et al.Bone Marrow Transplantation|March 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.Vox Sanguinis|January 1, 1985
Whole blood immunoadsorption of anti-A or anti-B antibodiesW I Bensinger, C D Buckner, R A CliftPageof 38